文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

免疫反应亚表型预测脓毒症死亡:资源有限地区的前瞻性研究

Immune Response Subphenotyping to Predict Mortality in Sepsis: A Prospective Study in Resource-Limited Setting.
PubMed 文献 · Crit Care Explor · 2025-09-09
一句话结论在资源有限地区,巨噬细胞活化样综合征(MALS,铁蛋白>4420 ng/mL)是脓毒症院内死亡的独立预测因子(校正HR 1.7)。

这项前瞻性队列研究在三级医院的急诊科、住院病房和ICU开展。纳入24小时内诊断为脓毒症的成年患者,排除有红细胞输注史、重型地中海贫血、失代偿期肝硬化、血液系统恶性肿瘤或使用免疫抑制/长期皮质类固醇治疗者。按铁蛋白>4420 ng/mL定义为MALS、mHLA-DR<10,000受体/细胞且铁蛋白≤4420 ng/mL定义为免疫麻痹进行分型。200例中MALS组54例(27%)、免疫麻痹组19例(9.5%),其余为未分类组;三组院内死亡率分别为83.3%、68.4%、51.1%。MALS亚表型是脓毒症院内死亡的独立预测因子(校正HR 1.7;95%CI 1.13-2.49;P=0.01)。

要点

  • 200例脓毒症患者中,MALS组54例(27%),免疫麻痹组19例(9.5%),其余为未分类组。
  • MALS组院内死亡率为83.3%,免疫麻痹组68.4%,未分类组51.1%。
  • MALS与未分类组比较,粗HR 2.3(95%CI 1.56-3.35)。
  • 校正混杂因素后,MALS的校正HR为1.7(95%CI 1.13-2.49;P=0.01)。
  • 免疫麻痹与未分类组比较,粗HR 1.4(95%CI 0.76-2.50)。

适用人群与场景

  • 纳入标准:在三级医院急诊科、住院病房或ICU就诊、24小时内诊断为脓毒症的成年患者。
  • 排除标准:有红细胞输注史、重型地中海贫血、失代偿期肝硬化、血液系统恶性肿瘤,或使用免疫抑制治疗或长期皮质类固醇治疗者。

诊断标准与关键阈值

  • MALS:血清铁蛋白>4420 ng/mL。
  • 免疫麻痹:单核细胞HLA-DR(mHLA-DR)<10,000受体/细胞且铁蛋白≤4420 ng/mL。
  • 未分类:不符合MALS或免疫麻痹标准者。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,在三级医院的急诊科、住院病房和ICU开展,纳入200例24小时内诊断为脓毒症的成年患者。
  • 亚表型分布:MALS组54例(27%),免疫麻痹组19例(9.5%),其余为未分类组。
  • 主要终点院内死亡率:MALS组83.3%,免疫麻痹组68.4%,未分类组51.1%。
  • MALS与未分类组比较,满足比例风险假设,粗HR 2.3(95%CI 1.56-3.35);校正混杂因素后,MALS的校正HR为1.7(95%CI 1.13-2.49;P=0.01)。
  • 免疫麻痹与未分类组比较,不满足比例风险假设,粗HR 1.4(95%CI 0.76-2.50)。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,MALS亚表型是脓毒症院内死亡的独立预测因子。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Sepsis remains a leading cause of death in infectious cases. The heterogeneity of immune responses is a major challenge in the management and prognostication of patients with sepsis. Identifying distinct immune response subphenotypes using parsimonious classifiers may improve outcome prediction, particularly in resource-limited settings.

OBJECTIVES: This study aimed to evaluate whether classification of the immune response can serve as a predictor of mortality.

DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was conducted in the emergency department, inpatient wards, and ICU of a tertiary hospital. Adult patients diagnosed with sepsis within the previous 24 hours were included. Exclusion criteria were history of RBC transfusion, major thalassemia, decompensated cirrhosis, hematologic malignancy, or use of immunosuppressive or chronic corticosteroid therapy. Demographic, clinical, and laboratory data-including serum ferritin and monocyte human leukocyte antigen-DR/Human Leukocyte Antigen-DR) (mHLA-DR) levels-were collected.

MAIN OUTCOMES AND MEASURES: Subjects were classified into the following immune subphenotypes: macrophage activation-like syndrome (MALS) (if ferritin > 4420 ng/mL), immunoparalysis (if mHLA-DR < 10,000 receptors/cell and ferritin ≤ 4420 ng/mL), and unclassified (if they did not meet the criteria for either MALS or immunoparalysis). The primary outcome was in-hospital mortality.

RESULTS: Of the 200 subjects recruited, 54 (27%) were classified into the MALS group, 19 (9.5%) into the immunoparalysis group, and the remainder into the unclassified group. The in-hospital mortality rates for the MALS, immune paralysis, and unclassified groups were 83.3%, 68.4%, and 51.1%, respectively. The proportional hazards assumption was met between the MALS and unclassified groups (crude hazard ratio [HR] 2.3; 95% CI, 1.56-3.35) but not between the immunoparalysis and unclassified groups (crude HR 1.4; 95% CI, 0.76-2.50). After adjusting for confounding variables, MALS's adjusted HR was 1.7 (95% CI, 1.13-2.49; p = 0.01).

CONCLUSIONS AND RELEVANCE: The MALS subphenotype is an independent predictor of in-hospital mortality in sepsis.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Herwanto V, Sinto R, Nainggolan L, et al. Immune Response Subphenotyping to Predict Mortality in Sepsis: A Prospective Study in Resource-Limited Setting. Crit Care Explor. 2025. PMID: 40924910. doi:10.1097/CCE.0000000000001315

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。